Diagnosis and treatment of attention deficit hyperactivity disorder, a childhood-onset problem of hyperactivity, inattention and impulsiveness that may persist into teen years and even beyond, affecting girls as well as boys.
Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
An examination of the causes of traumatic brain injury, the mechanisms of primary and secondary injury, and how those injuries are evaluated and classified.
Physicians should fully understand the ethical principles and professional standards involved in making decisions for the treatment of impaired newborns.
Two physicians give an overview of the iPledge program and discuss the problematic aspects of the program for physicians who prescribe isotretinoin and their patients.